This Series D funding will be used to sustain further growth for Voalte. Voalte has seen a rapidly expanding customer base, with last quarter signing on 44 new sites with Voalte technology.
Trey Lauderdale, Founder and CEO of Voalte is looking forward to watching Voalte expand thanks to the funding.
“I’m excited about the partnership and how it will enable us to continue to push the envelope on advancing healthcare communication,” said Lauderdale.
This is not the first time Bedford Funding is backing Voalte. In February 2014, Bedford Funding invested $36 million in Voalte.
To read more about the funding, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
